YZYingdong Zhang

Yingdong Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingdong Zhang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Jie Lu

    Department of Neurology, Nanjing Brain Hospital, Nanjing Medical University, Nanjing, P.R. China

    3 shared publications
  • Li Gao

    Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, P.R. China

    3 shared publications
  • Jun Guo

    Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu Province, P. R. China

    2 shared publications
  • Teng Jiang

    Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, P.R. China

    2 shared publications
  • Yi Liu

    Department of Neurology, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, P. R. China

    2 shared publications
  • Bian-Rong Wang

    Department of Neurology, Jiangsu Geriatric Hospital, Nanjing, Jiangsu Province 210024, PR China

    1 shared publication

Latest Publications

    • 1 July 2013
      • Vol. 52  (7) , 558-61

    [The pulmonary function and respiratory muscle power in multiple systemic atrophy and Parkinson's disease].

    by Yao Wang, Ying-Dong Zhang, Li Gao, Jie Lu, Hao Gu, Li-Hua Sun, Yan Tan, Yun Liu, Jian-Ping Zhang

    To investigate the characteristics of pulmonary function and respiratory muscle performance in patients with multiple system atrophy (MSA) and Parkinson's disease (PD). Pulmonary function and respiratory muscle strength were evaluated in 16 MSA patients and 20 PD patients. Another 17 age and sex-matched healthy volunteers were recruited as controls. Carbon monoxide diffusion capacity (DLCO) was significantly decreased in MSA group compared with PD group [(62.86 ± 15.66)% vs (76.67 ± 18.98)%, respectively, P < 0.05]. Maximal inspiration pressure (MIP) and maximal expiration pressure (MEP) were (39.08 ± 22.99)% and (49.59 ± 22.97)% in MSA group, (39.83 ± 24.83)% and (49.26 ± 22.86)% in PD group. Both MIP and MEP in MSA and PD groups were significantly reduced compared with controls [(57.44 ± 19.90)%, P < 0.05; (77.10 ± 21.46)%, P < 0.001]. Our findings suggest that respiratory dysfunction is involved in MSA and PD. The reduction of respiratory muscle strength is remarkable. The insufficiency of pulmonary diffusion function is more severe in MSA than in PD. More attention should be paid to the compromised respiratory function in neurodegenerative disorders.

  • Open Access

    ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke

    by Teng Jiang, Li Gao, Jie Lu, Ying-Dong Zhang

    The renin-angiotensin system (RAS) in brain is a crucial regulator for physiological homeostasis and diseases of cerebrovascular system, such as ischemic stroke. Overactivation of brain Angiotensin-converting enzyme (ACE) - Angiotensin II (Ang II) - Angiotensin II type 1 receptor (AT1R) axis was found to be involved in the progress of hypertension, atherosclerosis and thrombogenesis, which increased the susceptibility to ischemic stroke. Besides, brain Ang II levels have been revealed to be increased in ischemic tissues after stroke, and contribute to neural damage through elevating oxidative stress levels and inducing inflammatory response in the ischemic hemisphere via AT1R. In recent years, new components of RAS have been discovered, including ACE2, Angiotensin-(1-7) [Ang-(1-7)] and Mas, which constitute ACE2-Ang-(1-7)-Mas axis. ACE2 converts Ang II to Ang-(1-7), and Ang-(1-7) binds with its receptor Mas, exerting benefical effects in cerebrovascular disease. Through interacting with nitric oxide and bradykinin, Ang-(1-7) could attenuate the development of hypertension and the pathologic progress of atherosclerosis. Besides, its antithrombotic activity also prevents thrombogenic events, which may contribute to reduce the risk of ischemic stroke. In addition, after ischemia insult, ACE2-Ang-(1-7)-Mas has been shown to reduce the cerebral infarct size and improve neurological deficits through its antioxidative and anti-inflammatory effects. Taken together, activation of the ACE2-Ang-(1-7)-Mas axis may become a novel therapeutic target in prevention and treatment of ischemia stroke, which deserves further investigations.


  • Open Access

    Inhibition of Autophagy Contributes to Ischemic Postconditioning-Induced Neuroprotection against Focal Cerebral Ischemia in Rats

    by Li Gao, Teng Jiang, Jun Guo, Yi Liu, Guiyun Cui, Lize Gu, Lingying Su, Yingdong Zhang

    Ischemic postconditioning (IPOC), or relief of ischemia in a stuttered manner, has emerged as an innovative treatment strategy to reduce programmed cell death, attenuate ischemic injuries, and improve neurological outcomes. However, the mechanisms involved have not been completely elucidated. Recent studies indicate that autophagy is a type of programmed cell death that plays elusive roles in controlling neuronal damage and metabolic homeostasis. This study aims to determine the role of autophagy in IPOC-induced neuroprotection against focal cerebral ischemia in rats. A focal cerebral ischemic model with permanent middle cerebral artery (MCA) occlusion plus transient common carotid artery (CCA) occlusion was established. The autophagosomes and the expressions of LC3/Beclin 1/p62 were evaluated for their contribution to the activation of autophagy. We found that autophagy was markedly induced with the upregulation of LC3/Beclin 1 and downregulation of p62 in the penumbra at various time intervals following ischemia. IPOC, performed at the onset of reperfusion, reduced infarct size, mitigated brain edema, inhibited the induction of LC3/Beclin 1 and reversed the reduction of p62 simultaneously. Rapamycin, an inducer of autophagy, partially reversed all the aforementioned effects induced by IPOC. Conversely, autophagy inhibitor 3-methyladenine (3-MA) attenuated the ischemic insults, inhibited the activation of autophagy, and elevated the expression of anti-apoptotic protein Bcl-2, to an extent comparable to IPOC. The present study suggests that inhibition of the autophagic pathway plays a key role in IPOC-induced neuroprotection against focal cerebral ischemia. Thus, pharmacological inhibition of autophagy may provide a novel therapeutic strategy for the treatment of stroke.


  • Open Access

    Suppressing inflammation by inhibiting the NF‐κB pathway contributes to the neuroprotective effect of angiotensin‐(1‐7) in rats with permanent cerebral ischaemia

    by Teng Jiang, Li Gao, Jun Guo, Jie Lu, Yao Wang, Yingdong Zhang

    BACKGROUND AND PURPOSE Angiotensin‐(1‐7) [Ang‐(1‐7)] has anti‐inflammatory effects in peripheral organs, but its effects in ischaemic stroke are unclear as yet. We investigated whether its anti‐inflammatory effect contributes to the neuroprotection induced by Ang‐(1‐7) in a rat model of permanent middle cerebral artery occlusion (pMCAO).EXPERIMENTAL APPROACH We infused Ang‐(1‐7), Mas receptor antagonist A‐779, angiotensin II type 2 receptor antagonist PD123319 or artificial CSF into the right lateral ventricle of male Sprague‐Dawley rats from 48 h before onset of pMCAO until the rats were killed. Twenty‐four hours after pMCAO, the neuroprotective effect of Ang‐(1‐7) was analysed by evaluating infarct volume and neurological deficits. The levels of oxidative stress were detected by spectrophotometric assay. The activation of NF‐κB was assessed by Western blot and immunohistochemistry analysis. The level of COX‐2 was tested by Western blot analysis and concentrations of pro‐inflammatory cytokines were measured by elisa.KEY RESULTS Infusion of Ang‐(1‐7), i.c.v., significantly reduced infarct volume and improved neurological deficits. It decreased the levels of oxidative stress and suppressed NF‐κB activity, which was accompanied by a reduction of pro‐inflammatory cytokines and COX‐2 in the peri‐infarct regions. These effects of Ang‐(1‐7) were reversed by A‐779 but not by PD123319. Additionally, infusion of A‐779 alone increased oxidative stress levels and enhanced NF‐κB activity, which was accompanied by an up‐regulation of pro‐inflammatory cytokines and COX‐2.CONCLUSION AND IMPLICATIONS Our findings indicate that suppressing NF‐κB dependent pathway via Mas receptor may represent one mechanism that contributes to the anti‐inflammatory effects of Ang‐(1‐7) in rats with pMCAO.


  • Short amyloid-beta immunogens show strong immunogenicity and avoid stimulating pro-inflammatory pathways in bone marrow-derived dendritic cells from C57BL/6J mice in vitro

    by Jian-Quan Shi, Jun Chen, Bian-Rong Wang, Yin-Wei Zhu, Yan Xu, Jun Wang, Hang Xiao, Jing-Ping Shi, Ying-Dong Zhang, Jun Xu